Seeing Is Believing
Currently out of the existing stock ratings of Caitlin Cronin, 44 are a BUY (69.84%), 19 are a HOLD (30.16%).
Analyst Caitlin Cronin, currently employed at CANACCORD, carries an average stock price target met ratio of 57.09% that have a potential upside of 32.14% achieved within 122 days.
Caitlin Cronin’s has documented 123 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BVS, Bioventus at 17-Aug-2026.
Analyst best performing recommendations are on KRMD (REPRO MED SYSTEMS).
The best stock recommendation documented was for SNN (SMITH & NEPHEW SNATS) at 5/11/2026. The price target of $30 was fulfilled within 1 day with a profit of $0.9 (3.09%) receiving and performance score of 30.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2026
$16
$5.97 (59.52%)
$15
2 months ago
(05-Aug-2026)
0/2 (0%)
$6.43 (67.19%)
Buy Since 19-Oct-2020
$13
$2.97 (29.61%)
$11
2 months ago
(05-Aug-2026)
6/10 (60%)
$3.43 (35.84%)
255
Buy Since 01-Aug-2024
$12
$1.97 (19.64%)
$11
2 months ago
(05-Aug-2026)
2/4 (50%)
$2.43 (25.39%)
234
Buy Since 09-Mar-2026
$13
$2.97 (29.61%)
$20
2 months 27 days ago
(08-Jul-2026)
1/4 (25%)
$3.79 (41.15%)
13
Buy Since 05-Aug-2019
$14
$3.97 (39.58%)
$14
4 months 7 days ago
(28-May-2026)
19/23 (82.61%)
$6.11 (77.44%)
542
Which stock is Caitlin Cronin most bullish on?
Which stock is Caitlin Cronin most reserved on?
What Year was the first public recommendation made by Caitlin Cronin?